The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 17-24

  Lu, Jia Huan ^a   Shi, Zhi Feng ^b   Xu, Hui ^a  

^a Shanghai Changning Center Hospital   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cyp D; Doxorubicin; Lung cancer; p53 and cell death

Indexed keywords

CYCLOPHILIN D; CYCLOSPORIN A; DOXORUBICIN; MITOCHONDRIAL DNA; PIFITHRIN ALPHA; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG ADENOCARCINOMA; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CYCLOPHILINS; CYCLOSPORINE; DOXORUBICIN; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIA; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896542308     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1922-1     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11-30
2. Cagle PT (2013) The new American Cancer Society Lung Cancer Screening guidelines and the role of the pathologist. Arch Pathol Lab Med 137:451
3. Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW (2013) Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 63:88-105
4. Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ, Livingston RB, Gandara DR (2005) Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 23:2955-2961 (Pubitemid 46224114)
5. Vatsyayan R, Chaudhary P, Lelsani PC, Singhal P, Awasthi YC, Awasthi S, Singhal SS (2009) Role of RLIP76 in doxorubicin resistance in lung cancer. Int J Oncol 34:1505-1511
6. von Pawel J, Schiller JH, Shepherd FA, Fields SZ, Kleisbauer JP, Chrysson NG, Stewart DJ, Clark PI, Palmer MC, Depierre A, Carmichael J, Krebs JB, Ross G, Lane SR, Gralla R (1999) Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 17:658-667 (Pubitemid 29075255)
7. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468 (Pubitemid 14012819)
8. Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP, Opipari AW Jr (2001) NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 276:48921-48929
9. Mukhopadhyay P, Rajesh M, Batkai S, Kashiwaya Y, Hasko G, Liaudet L, Szabo C, Pacher P (2009) Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 296:H1466-H1483
10. Liu J, Mao W, Ding B, Liang CS (2008) ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol 295:H1956-H1965
11. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE (1996) Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2:811-814 (Pubitemid 26225099)
12. Marine JC (2010) Pharmacological rescue of p53 in cancer therapy: widening the sensitive tumor spectrum by targeting MDMX. Cancer Cell 18:399-400
13. Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899-2908 (Pubitemid 40638098)
14. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM (2012) p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149:1536-1548
15. Baumann K (2012) Cell death: multitasking p53 promotes necrosis. Nat Rev Mol Cell Biol 13:480-481
16. Chen MB, Shen WX, Yang Y, Wu XY, Gu JH, Lu PH (2011) Activation of AMP-activated protein kinase is involved in vin-cristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol 226:1915-1925
17. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590 (Pubitemid 36385115)
18. Ji C, Yang B, Yang Z, Tu Y, Yang YL, He L, Bi ZG (2012) Ultra-violet B (UVB)-induced skin cell death occurs through a cyclophilin D intrinsic signaling pathway. Biochem Biophys Res Commun 425:825-829
19. Wang H, Li H, Zuo M, Zhang Y, Liu H, Fang W, Chen X (2008) L2-32c, a novel taxane and its antitumor activities in vitro and in vivo. Cancer Lett 268:89-97
20. Chen B, Xu M, Zhang H, Wang JX, Zheng P, Gong L, Wu GJ, Dai T (2013) Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling. Biochem Biophys Res Commun 437(4):526-531
21. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning andmemory in Alzheimer's disease. NatMed 14:1097-1105
22. Du H, Guo L, Zhang W, Rydzewska M, Yan S (2011) Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiol Aging 32:398-406
23. Javadov S, Kuznetsov A (2013) Mitochondrial permeability transition and cell death: the role of cyclophilin d. Front Physiol 4:76
24. Kwok TT, Mok CH, Menton-Brennan L (1994) Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. Cancer Res 54:2834-2836 (Pubitemid 24187756)
25. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LL, Cheng AL (2004) Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 23:3580-3588 (Pubitemid 38658424)